ClinicalTrials.Veeva

Menu
P

Psychiatric Associates | Overland Park, KS

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SHP465
Viloxazine
Dasotraline
Rapastinel
Lisdexamfetamine dimesylate
Lisdexamfetamine Dimesylate
SPD489
SPN-812
Eszopiclone
Guanfacine Hydrochloride

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 50 total trials

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Invitation-only
Migraine
Drug: Ubrogepant

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Enrolling
Migraine
Drug: Placebo-Matching Ubrogepant
Drug: Ubrogepant

Trial sponsors

Shire logo
Sumitomo Pharma logo
Supernus Pharmaceuticals logo
AbbVie logo
Allergan logo
Pfizer logo
E
Forest Laboratories logo
N
Otsuka logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems